Medicinova (MNOV) Long-Term Debt Issuances (2010 - 2011)
Medicinova (MNOV) posted quarterly Long-Term Debt Issuances of $15.9 million for Q2 2011, up 1949.03% quarter-over-quarter from -$857619.0 in Q1 2011.
Medicinova (MNOV) Long-Term Debt Issuances (2010 - 2011) Analysis & Trends
Medicinova (MNOV) has reported Long-Term Debt Issuances for 2 consecutive years, with $15.9 million the latest figure, recorded in Q2 2011.
- In Q2 2011, Long-Term Debt Issuances changed N/A year-over-year to $15.9 million; the TTM figure through Dec 2011 stood at $15.0 million (changed N/A YoY), while the FY2011 annual figure was $15.0 million, up 2.25% from the prior year.
- Long-Term Debt Issuances improved to $15.9 million in Q2 2011 per MNOV's latest filing, from -$857619.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $15.9 million in Q2 2011 and bottomed at -$857619.0 in Q1 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 15.86 Mn |
| Jun 30, 2011 | 15.86 Mn |
| Mar 31, 2011 | -857,619.00 |
| Mar 31, 2011 | -857,619.00 |
| Dec 31, 2010 | 14.67 Mn |
| Dec 31, 2010 | 14.67 Mn |